Total Payments
$18,306
2024 Payments
$1,159
Companies
40
Transactions
666
Medicare Patients
2,950
Medicare Billing
$412,336
Payment Breakdown by Category
Food & Beverage$13,472 (73.6%)
Other$4,800 (26.2%)
Gifts$34.47 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,472 | 663 | 73.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,800 | 2 | 26.2% |
| Gift | $34.47 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Synergy Pharmaceuticals Inc | $5,300 | 28 | $0 (2018) |
| ABBVIE INC. | $3,056 | 113 | $0 (2024) |
| Janssen Biotech, Inc. | $1,343 | 78 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,278 | 106 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $776.91 | 40 | $0 (2023) |
| Celgene Corporation | $745.49 | 52 | $0 (2023) |
| Gilead Sciences, Inc. | $680.54 | 25 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $580.49 | 11 | $0 (2022) |
| GENZYME CORPORATION | $500.12 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $382.31 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,159 | 27 | ABBVIE INC. ($348.50) |
| 2023 | $2,328 | 98 | ABBVIE INC. ($621.89) |
| 2022 | $2,129 | 103 | ABBVIE INC. ($539.54) |
| 2021 | $1,309 | 67 | Janssen Biotech, Inc. ($371.87) |
| 2020 | $568.71 | 23 | Gilead Sciences, Inc. ($189.63) |
| 2019 | $1,776 | 119 | Takeda Pharmaceuticals U.S.A., Inc. ($463.24) |
| 2018 | $7,168 | 126 | Synergy Pharmaceuticals Inc ($5,227) |
| 2017 | $1,868 | 103 | AbbVie, Inc. ($443.26) |
All Payment Transactions
666 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: GI | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $114.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $145.23 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $100.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Immunology | ||||||
| 06/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: VIROLOGY | ||||||
| 05/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Immunology | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.93 | General |
| Category: Neuroscience | ||||||
| 05/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Immunology | ||||||
| 04/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Immunology | ||||||
| 04/24/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: Immunology | ||||||
| 03/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: GI | ||||||
| 02/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 656 | 775 | $302,789 | $87,301 |
| 2022 | 11 | 699 | 846 | $308,375 | $89,494 |
| 2021 | 15 | 830 | 1,033 | $377,185 | $117,590 |
| 2020 | 15 | 765 | 1,846 | $436,540 | $117,951 |
Total Patients
2,950
Total Services
4,500
Medicare Billing
$412,336
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 176 | 308 | $55,440 | $31,244 | 56.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 90 | 90 | $72,000 | $19,327 | 26.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 93 | 93 | $69,750 | $9,345 | 13.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 97 | 99 | $54,450 | $9,187 | 16.9% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2021 | 12 | 12 | $19,200 | $8,567 | 44.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 115 | $13,225 | $8,319 | 62.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 40 | 40 | $28,000 | $7,790 | 27.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $11,700 | $5,054 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 77 | $9,240 | $4,618 | 50.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 19 | 19 | $13,300 | $3,456 | 26.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 21 | 21 | $14,700 | $3,036 | 20.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 31 | $5,580 | $2,670 | 47.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 53 | 66 | $5,280 | $2,110 | 40.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $3,120 | $1,824 | 58.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,200 | $1,042 | 47.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2020 | 13 | 940 | $141,000 | $39,157 | 27.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 72 | 72 | $57,600 | $15,735 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 193 | $34,740 | $15,301 | 44.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 95 | 98 | $53,900 | $9,193 | 17.1% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 91 | 91 | $68,250 | $8,370 | 12.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 114 | 152 | $17,480 | $7,899 | 45.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 29 | 29 | $20,300 | $5,460 | 26.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 60 | 74 | $8,880 | $4,522 | 50.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 36 | 36 | $10,800 | $4,037 | 37.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 13 | 21 | $7,560 | $2,449 | 32.4% |
About Dr. Randall Jacobs, MD
Dr. Randall Jacobs, MD is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093798316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randall Jacobs, MD has received a total of $18,306 in payments from pharmaceutical and medical device companies, with $1,159 received in 2024. These payments were reported across 666 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($13,472).
As a Medicare-enrolled provider, Jacobs has provided services to 2,950 Medicare beneficiaries, totaling 4,500 services with total Medicare billing of $412,336. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Fort Myers, FL
- Active Since 11/21/2005
- Last Updated 09/26/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1093798316
Products in Payments
- Trulance (Drug) $5,300
- STELARA (Biological) $1,111
- ZEPOSIA (Drug) $959.37
- DUPIXENT (Biological) $882.43
- Entyvio (Biological) $682.51
- SKYRIZI (Biological) $629.80
- RINVOQ (Biological) $529.05
- XIFAXAN (Drug) $412.99
- Humira (Biological) $411.00
- OCA (Drug) $356.11
- ENTYVIO (Biological) $338.96
- Linzess (Drug) $315.10
- VOQUEZNA (Drug) $278.15
- IBSRELA (Drug) $256.59
- REMICADE (Biological) $256.57
- Epclusa (Drug) $236.65
- OCALIVA (Drug) $224.38
- Mavyret (Drug) $218.48
- HUMIRA (Biological) $217.14
- XELJANZ (Drug) $212.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Gastroenterology $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Gastroenterology $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Gastroenterology $9,721
Robert Janda, Md, MD
Gastroenterology — Payments: $8,904
Gastroenterology $8,904
David Elliott, Do, DO
Gastroenterology — Payments: $8,680
Gastroenterology $8,680
Ramesh Koka, M.d, M.D
Gastroenterology — Payments: $8,404
Gastroenterology $8,404